DMU-212
CAS No. 134029-62-2
DMU-212( —— )
Catalog No. M28078 CAS No. 134029-62-2
DMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 27 | Get Quote |
|
| 5MG | 43 | Get Quote |
|
| 10MG | 72 | Get Quote |
|
| 25MG | 147 | Get Quote |
|
| 50MG | 259 | Get Quote |
|
| 100MG | 385 | Get Quote |
|
| 500MG | 872 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDMU-212
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.
-
DescriptionDMU-212, a methylated form of Resveratrol, shows antimitotic, antiproliferative, and antioxidant activities. DMU-212 induces mitotic arrest through the activation of ERK1/2 protein and the promotion of apoptosis.(In Vitro):DMU-212 (0.3125-40 μM) inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM, 0.5 μM, 1.25 μM, and 1.25 μM for A375, Bro, MeWo, and M5 human melanoma cells, respectively.).(In Vivo):In SCID female mice, DMU-212 (50 mg/kg; i.g.) inhibited tumor growth and lowered tumor burden.
-
In VitroCell Proliferation Assay Cell Line:A375 cells, MeWo cells, M5 cells, Bro cells Concentration:0.3125 μM, 0,625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM Incubation Time:96 hours Result:Inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM for A375 and Bro and IC50= 1.25 μM for MeWo and M5 cells).Cell Cycle Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hoursResult:Caused a marked increase in the levels of p21, p53 and cyclin B1 proteins with a concomitant decrease in the levels of cyclin A2.Western Blot Analysis Cell Line:A375 cells Concentration:20 μM, 30 μM, 50 μM Incubation Time:24 hours Result:Significant upregulated Bax, caspase 3 and caspase 9 protein levels, while decreased the levels of the anti-apoptotic protein Bcl-2.Apoptosis Analysis Cell Line:A375 cells Concentration:10 μM, 20 μM Incubation Time:24 hours, 36 hoursResult:Induced apoptosis.
-
In VivoAnimal Model:6-weeks-old SCID female mice (20-24 g), with ovarian cancer xenografts Dosage:50 mg/kg Administration:Oral gavage, three times a week, for 14 days Result:Lowered tumor burden.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorTubulin polymerization
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number134029-62-2
-
Formula Weight300.35
-
Molecular FormulaC18H20O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (66.59 mM)
-
SMILESCOC1=CC=C(/C=C/C2=CC(OC)=C(OC)C(OC)=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schneider Y, et al. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer. 2003 Nov 1;107(2):189-96.
molnova catalog
related products
-
3-O-Methylgallic aci...
3,4-Dihydroxy-5-methoxybenzoic acid reduces cell proliferation in Caco-2 cells(IC50 = 24.1 μM) more effectively than anthocyanins and may offer protection against colon cancer after its formation in the gut. 3,4-Dihydroxy-5-methoxybenzoic acid inhibits transcription factors NF-κB, AP-1, STAT-1, and OCT-1 which are known to be activated in colorectal cancer.
-
Atrosab
Atrosab is a humanized IgG1 antibody targeting TNFR1, inhibiting TNF-mediated apoptosis, and can be used to study inflammatory and neurodegenerative diseases.
-
p53 Activator 7
p53 Activator 7 is a highly potent and cell-permeable activator of the p53 mutation Y220C (MDM-2/p53), which induces apoptosis.
Cart
sales@molnova.com